Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,836Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5BRISTOL-MYERS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FEDRATINIB HYDROCHLORIDE

US Patent Number : 10391094

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212327

Patent Use Code : U-2607

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-06-04

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FEDRATINIB HYDROCHLORIDE

US Patent Number : 8138199

Drug Substance Claim :

Drug Product Claim :

Application Number : 212327

Patent Use Code : U-2607

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-30

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FEDRATINIB HYDROCHLORIDE

US Patent Number : 11400092

Drug Substance Claim :

Drug Product Claim :

Application Number : 212327

Patent Use Code : U-3409

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-09-24

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FEDRATINIB HYDROCHLORIDE

US Patent Number : 7825246

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212327

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-16

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FEDRATINIB HYDROCHLORIDE

US Patent Number : 7528143

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212327

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-11-16

blank